EUVIMEDEUVIMED entdecken
Korrektur

Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”

Cancer · 15.11.2026 · 132 (22)

DOI: 10.1002/cncr.70667 ↗

Kurz gefasst

Korrektur in der Zeitschrift Cancer, online erschienen am 06.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”. Cancer, 132(22). https://doi.org/10.1002/cncr.70667

Vancouver

Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”. Cancer. 2026;132(22). doi:10.1002/cncr.70667

BibTeX
@article{euvimed2026,
  title = {Correction to “Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis”},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {22},
  doi = {10.1002/cncr.70667}
}
Kostenlos starten →